800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension (ICoN-1)

view all Clinical Trials

Overview

This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)

Clinical Trial Information

Protocol

TIRB#: 31811

Phase

3

Condition(s)

Mycobacterium Avium Complex (MAC)

Investigator

Daniel Salerno, MD

Coordinator

Joseph Lambert, Gayle Jones

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazimine Inhalation Suspension When Added to Guideline-Based Therapy in Participants With Nontuberculous Mycobacterial Infection